Download PDF
CC BY-NC-ND 4.0 · World J Nucl Med 2022; 21(01): 080-082
DOI: 10.1055/s-0042-1746172
Interesting Case

Unexpected Rare Association of Secondary Breast, Thyroid, and Ovarian Lymphomas in a Female Patient with Burkitt Lymphoma: PET-CT Findings

Salah Nabih Ouriagli
1   Military Teaching Hospital, Rabat, Morocco
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

We report the case of a 15-year-old female, followed for Burkitt lymphoma with initial ovarian presentation. Positron emission tomography-computed tomography (PET-CT) with 18F-fluorodeoxyglucose (18F-FDG) performed to evaluate initial extension assessment showed an unexpected association with secondary breast, thyroid, and ovarian lymphomas. To our knowledge, this association is very rare, unusual, and these extranodal presentations have been reported in literature as a separate case report. Authors highlight performance of PET-CT with 18F-FDG to determinate the secondary origin of this multiglandular involvement, to establish a lesional map of the whole body, and to contribute to the therapeutic decision.

Keywords

secondary breast - thyroid and ovarian lymphomas - Burkitt lymphoma - PET-CT with 18F-FDG - case report


Publication History

Article published online:
30 April 2022

© 2022. World Association of Radiopharmaceutical and Molecular Therapy (WARMTH). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Bari A, Marcheselli L, Sacchi S. et al. Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. Ann Oncol 2010; 21 (07) 1486-1491
    CrossrefPubMedGoogle Scholar
  • 2 Lin YC, Tsai CH, Wu JS. et al. Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast–a review of 42 primary and secondary cases in Taiwanese patients. Leuk Lymphoma 2009; 50 (06) 918-924
    CrossrefPubMedGoogle Scholar
  • 3 Hu R, Miao M, Zhang R. et al. Ovary involvement of diffuse large B-cell lymphoma. Am J Case Rep 2012; 13: 96-98
    CrossrefPubMedGoogle Scholar
  • 4 Moore JB, Matthew CR, Hoang TD, Tracy HJ, Valentine JC, Shwayhat AF. Concurrent abdominal and thyroid lymphoma: a case report. AACE Clin Case Rep 2018; 4 (01) 51-55
    CrossrefGoogle Scholar
  • 5 Weingertner AS, Hamid D, Roedlich MN, Baldauf JJ. Non-Hodgkin malignant lymphoma revealed by an ovarian tumor case report and review of the literature. Gynecol Oncol 2004; 95 (03) 750-754
    CrossrefPubMedGoogle Scholar
  • 6 Sakurai N, Tateoka K, Taguchi J, Terada T. Primary precursor B-cell lymphoblastic lymphoma of the ovary: case report and review of the literature. Int J Gynecol Pathol 2008; 27 (03) 412-417
    CrossrefPubMedGoogle Scholar
  • 7 Holm LE, Blomgren H, Löwhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312 (10) 601-604
    CrossrefPubMedGoogle Scholar
  • 8 Feugier P, Van Hoof A, Sebban C. et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2005; 23 (18) 4117-4126
    CrossrefPubMedGoogle Scholar